G-quadruplex c-myc gene targeting compounds (TetraGene)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameG-quadruplex c-myc gene targeting compounds (TetraGene)
Drug Alias Namec-myc inhibitors (TetraGene)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMyc proto-oncogene protein inhibitors
TargetsMyc proto-oncogene protein
Therapy Area/IndicationsSolid tumoursHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTetragene
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTetragene
Active IndicationsN/A
Inactive IndicationsSolid tumoursHematologic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A